Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Quantitative assessment of finger motor impairment in multiple sclerosis.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Erratum.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Empyema presenting as lower extremity weakness.
Genetic proof for the transient nature of the Th17 phenotype.
Synchrony analysis: application in early diagnosis, staging and prognosis of multiple sclerosis.
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination.
Anesthesia for the obstetric patient with multiple sclerosis.
Sexual disorders in women with MS: Assessment and management.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
Multiple sclerosis: individualized disease susceptibility and therapy response.
An early British case of neuromyelitis optica (1850).
Fatigue, depression, and physical impairment in multiple sclerosis.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Leber hereditary optic neuropathy and multiple sclerosis: the mitochondrial connection.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Effect of a neurohospitalist service on outcomes at an academic medical center.
Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »
